Our services

DICE provides end-to-end clinical trial services, mainly focused on complex and oncological indications. Since 1989, we have supported the execution of more than 1300 clinical studies. Our 35+ years of expertise covers the full scope of clinical development, combining scientific, statistical and operational disciplines to deliver high-quality, reliable outcomes aligned with regulatory expectations.

How can we help you?

We support your study from early strategy to final reporting, bringing structure, clarity and consistency to every stage. From Phase I to IV studies, including EMA and FDA interactions, we work globally with experienced specialists in your indication. We operate across a wide range of therapeutic areas, including:

Oncology • Neurology • Ophthalmology • Haematology • Orphan diseases • Endocrinology • Gastroenterology • Pneumology • Urology • Autoimmune diseases • Diabetes • Metabolic disorders • Pediatric diseases

Our focus on complex studies and advanced technologies ensures efficient execution, reliable data and full regulatory alignment.

Full service with qualified partners

Full service with qualified partners

Consultancy

Full service with qualified partners

“Choosing DICE means working with a partner that understands your challenges"

“Choosing DICE means working with a partner that understands your challenges, delivers extremely high-quality data, and helps you save time and money.”
Dr. Daniela Marino
CEO and co-founder CUTTIS

Would you like to start a project with us?

If you are looking for a team that understands both the science and the process behind it, get a quote now. We will review it carefully and come back with a concrete proposal.